Cell Death: Caspases promote cell proliferation after necrosis
Necrosis is a form of cell death that can be caused by illness, infection, injury, radiation or chemicals. During necrosis, cells swell, burst and lyse, spilling their contents into the extracellular space, which attracts cells of the immune system and triggers inflammation. In humans, necrosis is irreversible and in severe cases, can lead to systemic organ failure and death (Khalid and Azimpouran, 2023).
However, recent research on fruit flies has revealed that some necrotic tissue can have surprisingly regenerative capabilities (Klemm et al., 2021; Yang et al., 2013). In these studies, necrosis was genetically induced in the wing imaginal disc, the precursor of the adult wings, by expressing a mutant Glutamate receptor (GluR1) that triggers the influx of calcium ions into cells, causing them to burst and die. Over half of these flies had wings that appeared normal, suggesting that the necrotic damage caused by GluR1 must have been repaired or regenerated during wing development.
Apoptosis is a genetically controlled form of cell death mediated by enzymes called caspases, and GluR1-induced necrosis is associated with two batches of apoptotic cells. The first batch is found at the edge of the wound, while the second batch, termed necrosis-induced apoptotic cells, is found away from the wound. It is likely that the role of the first batch is to clear away cells from the site of the wound. Now, in eLife, Jacob Klemm, Chloe Van Hazel and Robin Harris at the Arizona State University report on the properties of the cells in the second batch (Klemm et al., 2024).
The researchers used the same genetic ablation system (expression of a leaking GluR1 channel) to induce necrotic cell death within the wing imaginal disc of fruit flies. This revealed that inhibition of apoptosis in the second batch of cells significantly inhibited the regenerative proliferation of necrotic tissue. This suggests that controlled apoptosis is necessary for effective tissue regeneration after necrosis. However, necrosis-induced apoptosis occurs shortly after the induction of necrosis, while regenerative proliferation only occurs much later (36–48 hours; Figure 1A–C). How can necrosis-induced apoptotic cells induce regenerative proliferation if they have already died?
Klemm et al. found that a significant fraction of necrosis-induced apoptotic cells did not undergo apoptosis. Instead, these cells – called necrosis-induced caspase positive (NiCP) cells because they contain caspases – survived and promoted regenerative proliferation. The experiments revealed that the regenerative proliferation mediated by NiCP cells depends on Dronc, a caspase that initiates apoptosis, but not on the effector caspases that execute apoptosis. Even though the effector caspases were active, they were only present at sub-lethal levels, which would explain why the NiCP cells survived during the regenerative process.
Dronc also has non-apoptotic functions. Indeed, it can mediate the proliferation of nearby cells in a process called apoptosis-induced proliferation, in which apoptotic cells can influence neighbouring cells to proliferate (Fogarty and Bergmann, 2017). Dronc’s function in regenerative proliferation after necrosis appears to be distinct from the mechanisms by which apoptosis might drive cell division, suggesting that Dronc can control regenerative proliferation through at least two non-apoptotic mechanisms: through activating signalling pathways that promote cell growth in apoptosis-induced proliferation, and through regulating cell division in NiCP-mediated regeneration (Figure 1C). These results suggest a versatile role for Dronc in proliferation and tissue regeneration beyond its canonical function in apoptosis.
The findings by Klemm et al. challenge the traditional view of apoptosis as being a solely destructive process and highlight its potential role in tissue repair and regeneration. They also underscore the interplay between different forms of cell death (necrosis and apoptosis) in tissue homeostasis and repair.
However, a number of questions about the complex interplay between cell death and regeneration remain open. For example, what signals mediate the formation of necrosis-induced apoptotic cells and NiCP cells away from the wound, and what receptors do these signals target? Possible candidates could be intracellular factors, called DAMPs (damage-associated molecular patterns), which are released during the lysis of necrotic cells. Moreover, we need to understand the non-apoptotic roles of Dronc more fully, and to establish how NiCP cells maintain effector caspases below a sub-lethal threshold to stay alive. It would also be interesting to see what role macrophages and other innate immune cells play in the regenerative response to necrosis.
Lastly, although necrotic damage can be induced in the entire wing disc, only cells in the developing wing pouch (and, to a much lesser extent, cells in the notum), are competent to become NiCPs and to induce regenerative proliferation, whereas cells in the hinge region of the disc are not. By understanding the factors that confer regenerative competence to specific regions of the wing disc, new fundamental principles of tissue regeneration may be uncovered. These insights could potentially be leveraged to develop novel therapeutic approaches for enhancing regenerative capacity in human tissues affected by necrotic damage, opening new avenues in regenerative medicine.
References
-
Killers creating new life: Caspases drive apoptosis-induced proliferation in tissue repair and diseaseCell Death and Differentiation 24:1390–1400.https://doi.org/10.1038/cdd.2017.47
-
Neuronal necrosis and spreading death in a Drosophila genetic modelCell Death & Disease 4:e723.https://doi.org/10.1038/cddis.2013.232
Article and author information
Author details
Publication history
Copyright
© 2024, Yarikipati and Bergmann
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 495
- views
-
- 54
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
- Stem Cells and Regenerative Medicine
Retinal degeneration in mammals causes permanent loss of vision, due to an inability to regenerate naturally. Some non-mammalian vertebrates show robust regeneration, via Muller glia (MG). We have recently made significant progress in stimulating adult mouse MG to regenerate functional neurons by transgenic expression of the proneural transcription factor Ascl1. While these results showed that MG can serve as an endogenous source of neuronal replacement, the efficacy of this process is limited. With the goal of improving this in mammals, we designed a small molecule screen using sci-Plex, a method to multiplex up to thousands of single-nucleus RNA-seq conditions into a single experiment. We used this technology to screen a library of 92 compounds, identified, and validated two that promote neurogenesis in vivo. Our results demonstrate that high-throughput single-cell molecular profiling can substantially improve the discovery process for molecules and pathways that can stimulate neural regeneration and further demonstrate the potential for this approach to restore vision in patients with retinal disease.
-
- Stem Cells and Regenerative Medicine
Adult mammals, unlike some lower organisms, lack the ability to regenerate damaged hearts through cardiomyocytes (CMs) dedifferentiation into cells with regenerative capacity. Developing conditions to induce such naturally unavailable cells with potential to proliferate and differentiate into CMs, that is, regenerative cardiac cells (RCCs), in mammals will provide new insights and tools for heart regeneration research. In this study, we demonstrate that a two-compound combination, CHIR99021 and A-485 (2C), effectively induces RCCs from human embryonic stem cell-derived TNNT2+ CMs in vitro, as evidenced by lineage tracing experiments. Functional analysis shows that these RCCs express a broad spectrum of cardiogenesis genes and have the potential to differentiate into functional CMs, endothelial cells, and smooth muscle cells. Importantly, similar results were observed in neonatal rat CMs both in vitro and in vivo. Remarkably, administering 2C in adult mouse hearts significantly enhances survival and improves heart function post-myocardial infarction. Mechanistically, CHIR99021 is crucial for the transcriptional and epigenetic activation of genes essential for RCC development, while A-485 primarily suppresses H3K27Ac and particularly H3K9Ac in CMs. Their synergistic effect enhances these modifications on RCC genes, facilitating the transition from CMs to RCCs. Therefore, our findings demonstrate the feasibility and reveal the mechanisms of pharmacological induction of RCCs from endogenous CMs, which could offer a promising regenerative strategy to repair injured hearts.